Commentary By David Shapiro, MD, Former Chief of Allergy and Immunology, Winthrop University Medical Center and New York Ear Infirmary Hospital, Attending Physician OPD Allergy and Immunology, New York Hospital (and most importantly, father of Neil Shapiro, MD)
I highly recommend a …
JAMA reported on two important “negative†trials: The results of the EVEREST trial, comparing tolvaptan (a novel vasopressin V2 receptor blocker) to placebo for the treatment of acute CHF exacerbation, indicate that this agent had no effect …
Welcome to Quick Thinking a new feature of Clinical Correlations. A case will be presented piece by piece to a faculty expert who will comment on their approach to the case as it unfolds. Differential diagnoses and diagnostic workups will form the …
Commentary By: Josh Olstein, PGY-3
Earlier this month the FDA approved Tekturna (aliskiren) the first drug in a novel class of antihypertensives that work by directly inhibiting renin. While Novartis has yet to release pricing information, don’t expect to see this …
Commentary by Cara Litvin, PGY-3
The results of one of the more remarkable studies from the meeting of the American College of Cardiology were presented on Monday, along with the simultaneous early publishing of the study online in the New England Journal of …
Our next med-surg conference is Thursday March 29 at 4:30pm. It will be comprised of two heated debates. The first will be a debate over the need for surgery in asymptomatic patients with a severe carotid artery stenosis featuring Greg Mints, MDÂ and …
It seemed to be a slow week in the medical literature, but that will likely change as the 2007 American College of Cardiology Scientific Session is now underway. Theheart.org has an excellent summary about what to expect from the meetings. …
Consultant: Robert Raicht, MD Professor of Medicine, Chief Division of Gastroenterology
Clinical Vignette:
The patient is a 50 year old male with a past medical history notable for type II diabetes, hypertension and recently treated right foot cellulitis and c.difficile colitis who …